ID   P66A_MOUSE              Reviewed;         629 AA.
AC   Q8CHY6; Q8BTQ2; Q8VEC9;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 2.
DT   07-APR-2021, entry version 147.
DE   RecName: Full=Transcriptional repressor p66 alpha;
DE   AltName: Full=GATA zinc finger domain-containing protein 2A;
GN   Name=Gatad2a;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=NOD; TISSUE=Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N, and FVB/N-3; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96; SER-103 AND SER-110, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18630941; DOI=10.1021/pr800223m;
RA   Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.;
RT   "Specific phosphopeptide enrichment with immobilized titanium ion affinity
RT   chromatography adsorbent for phosphoproteome analysis.";
RL   J. Proteome Res. 7:3957-3967(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96; SER-103 AND SER-110, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96; SER-103; SER-109 AND
RP   SER-110, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-221; ARG-245 AND ARG-536, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Embryo;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Transcriptional repressor (By similarity). Enhances MBD2-
CC       mediated repression. Efficient repression requires the presence of
CC       GATAD2B (By similarity). {ECO:0000250|UniProtKB:Q86YP4}.
CC   -!- SUBUNIT: Interacts with MBD2 and MBD3 (By similarity). Interaction with
CC       MBD2 is required for the enhancement of MBD2-mediated repression and
CC       for targeting to the chromatin (By similarity). Component of the MeCP1
CC       histone deacetylase complex (By similarity). Interacts with histone
CC       tails, including that of histones H2A, H2B, H3 and H4 (By similarity).
CC       This interaction is reduced by histone acetylation (By similarity).
CC       Interacts with ERCC6 (By similarity). {ECO:0000250|UniProtKB:Q86YP4}.
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250|UniProtKB:Q86YP4}.
CC       Note=Speckled nuclear localization requires both CR1 and CR2 regions.
CC       {ECO:0000250|UniProtKB:Q86YP4}.
CC   -!- DOMAIN: Both CR1 and CR2 regions are required for speckled nuclear
CC       localization. {ECO:0000250|UniProtKB:Q86YP4}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH19178.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH31407.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC40736.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK089074; BAC40736.1; ALT_INIT; mRNA.
DR   EMBL; BC019178; AAH19178.1; ALT_INIT; mRNA.
DR   EMBL; BC031407; AAH31407.1; ALT_INIT; mRNA.
DR   EMBL; BC038221; AAH38221.2; -; mRNA.
DR   CCDS; CCDS52567.1; -.
DR   RefSeq; NP_001106817.1; NM_001113346.1.
DR   RefSeq; XP_011240597.1; XM_011242295.2.
DR   BMRB; Q8CHY6; -.
DR   SMR; Q8CHY6; -.
DR   BioGRID; 231518; 13.
DR   ComplexPortal; CPX-953; MBD2/NuRD nucleosome remodeling and deacetylase complex.
DR   ComplexPortal; CPX-954; MBD3/NuRD nucleosome remodeling and deacetylase complex.
DR   IntAct; Q8CHY6; 8.
DR   MINT; Q8CHY6; -.
DR   STRING; 10090.ENSMUSP00000070229; -.
DR   iPTMnet; Q8CHY6; -.
DR   PhosphoSitePlus; Q8CHY6; -.
DR   EPD; Q8CHY6; -.
DR   jPOST; Q8CHY6; -.
DR   MaxQB; Q8CHY6; -.
DR   PaxDb; Q8CHY6; -.
DR   PeptideAtlas; Q8CHY6; -.
DR   PRIDE; Q8CHY6; -.
DR   ProteomicsDB; 294097; -.
DR   ABCD; Q8CHY6; 40 sequenced antibodies.
DR   Antibodypedia; 1819; 227 antibodies.
DR   Ensembl; ENSMUST00000116463; ENSMUSP00000112164; ENSMUSG00000036180.
DR   Ensembl; ENSMUST00000212478; ENSMUSP00000148474; ENSMUSG00000036180.
DR   GeneID; 234366; -.
DR   KEGG; mmu:234366; -.
DR   UCSC; uc009lyf.2; mouse.
DR   CTD; 54815; -.
DR   MGI; MGI:2384585; Gatad2a.
DR   eggNOG; KOG3740; Eukaryota.
DR   GeneTree; ENSGT00390000004097; -.
DR   InParanoid; Q8CHY6; -.
DR   OrthoDB; 885815at2759; -.
DR   PhylomeDB; Q8CHY6; -.
DR   Reactome; R-MMU-3214815; HDACs deacetylate histones.
DR   Reactome; R-MMU-6804758; Regulation of TP53 Activity through Acetylation.
DR   Reactome; R-MMU-73762; RNA Polymerase I Transcription Initiation.
DR   Reactome; R-MMU-8943724; Regulation of PTEN gene transcription.
DR   BioGRID-ORCS; 234366; 5 hits in 55 CRISPR screens.
DR   ChiTaRS; Gatad2a; mouse.
DR   PRO; PR:Q8CHY6; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   RNAct; Q8CHY6; protein.
DR   Bgee; ENSMUSG00000036180; Expressed in heart and 316 other tissues.
DR   ExpressionAtlas; Q8CHY6; baseline and differential.
DR   Genevisible; Q8CHY6; MM.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0016581; C:NuRD complex; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; ISS:UniProtKB.
DR   GO; GO:0021506; P:anterior neuropore closure; IMP:MGI.
DR   GO; GO:0001568; P:blood vessel development; IMP:MGI.
DR   GO; GO:0010172; P:embryonic body morphogenesis; IMP:MGI.
DR   GO; GO:0001701; P:in utero embryonic development; IMP:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0001842; P:neural fold formation; IMP:MGI.
DR   GO; GO:0012501; P:programmed cell death; IMP:MGI.
DR   InterPro; IPR040386; P66.
DR   InterPro; IPR032346; P66_CC.
DR   PANTHER; PTHR13455; PTHR13455; 1.
DR   Pfam; PF16563; P66_CC; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Isopeptide bond; Metal-binding; Methylation; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..629
FT                   /note="Transcriptional repressor p66 alpha"
FT                   /id="PRO_0000083501"
FT   ZN_FING         410..462
FT                   /note="GATA-type"
FT   REGION          140..174
FT                   /note="CR1; interaction with MBD2"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   REGION          335..478
FT                   /note="CR2; histone tail-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   COILED          135..170
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        402..407
FT                   /note="Poly-Ala"
FT   MOD_RES         20
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         96
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:19144319, ECO:0007744|PubMed:21183079"
FT   MOD_RES         103
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:19144319, ECO:0007744|PubMed:21183079"
FT   MOD_RES         109
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         110
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:19144319, ECO:0007744|PubMed:21183079"
FT   MOD_RES         133
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         185
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         221
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         245
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         253
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         268
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         270
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         280
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         335
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         338
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         509
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         536
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         536
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         543
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         545
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         553
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   MOD_RES         594
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   CROSSLNK        89
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   CROSSLNK        174
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   CROSSLNK        200
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   CROSSLNK        229
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   CROSSLNK        462
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   CROSSLNK        485
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   CROSSLNK        547
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   CROSSLNK        581
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   CROSSLNK        601
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YP4"
FT   CONFLICT        248
FT                   /note="Q -> QQ (in Ref. 1; BAC40736)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   629 AA;  67334 MW;  5EA79CC71C9E29A4 CRC64;
     MSEEACRTRS QKRTLEPDLT EDDVENKKMK MEKGSSELTV DGDSRVMPEP SAGSAQGLLR
     TTEAMGTGSG EGLLGDGPVD MRTSHSDMKS EKRPPSPDVI VLSDSEQPSS PRVNGLTTVA
     LKDTSTEALL KSSPEERERM IKQLKEELRL EEAKLVLLKK LRQSQIQKEA TAQKPTASSG
     STVTTPPPLV RGTQNIPAGK TSLQTSSTRI PGSIIPPPLV RGGQQVSAKL GPQASSQVVM
     PPLVRGAQIH NIRQHSSTGP PPLLLAPRAS VPSMQIQGQR IIQQGLIRVA NVPNTSLLVN
     IPQPTAASMK GTAVASAQAN STPTSVASVV ASAESPASRQ AAAKLALRKQ LEKTLLEIPP
     PKPPAPEMNF LPSAANNEFI YLVGLEEVVQ NLLETQAGRI SATAAAAVLS REPYMCVQCK
     TDFTCRWREK GGAVMCENCM TSNQKKALKV EHTSRLKAAF VKALQQEQEM EQRLLQQGVG
     TASIKAEPAA PHPTLKQVIK PRRKLAFRSG EARVWNNGSS LQASSQLSRG SATAPRGVLH
     TFSQSPKLQN AASATALVSR TGRHSERVVG TGKGTASNWK KTPLSTGGTL AFVSPSLAVH
     KTSSAVDRQR EYLLDMIPPR SIPQSATWK
//
